This study is currently not recruiting participants.

Insomnia in HIV: Studies I and II

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

There are two primary objectives of this study. The first is to compare 10-week changes in Insomnia Severity Index (ISI) scores in HIV-infected adults with clinically relevant insomnia severity and who are already receiving virologically suppressive antiretroviral therapy (ART) and are then randomized to either treatment with the SHUTi cognitive behavioral therapy program or to Usual Care (UC). The second is to compare measures of frailty and cognitive function between HIV-infected, virologically suppressed adults with and without clinically relevant insomnia severity.

Description

There are two primary objectives of this study. The first is to compare 10-week changes in Insomnia Severity Index (ISI) scores in HIV-infected adults with clinically relevant insomnia severity and who are already receiving virologically suppressive antiretroviral therapy (ART) and are then randomized to either treatment with the SHUTi cognitive behavioral therapy program or to Usual Care (UC). The second is to compare measures of frailty and cognitive function between HIV-infected, virologically suppressed adults with and without clinically relevant insomnia severity.

Details
Condition insomnia,HIV
Age 100years or below
Clinical Study IdentifierTX8599
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.